ED  BioGenerator


     Office Locations:

20 South Sarah Street
St. Louis, MO 63108
Phone: 314-615-6355



  • Early
  • Seed



  • Life Sciences & Healthcare



    BioGenerator is a privately funded, non-profit 501(c)(3) organization created to facilitate the formation of science companies in the St. Louis region. Founded in 2003, BioGenerator has been funded through the generosity of the McDonnell Family Foundation, the Danforth Foundation, Bunge North America, the Monsanto Fund and CORTEX. BioGenerator's mission is to support economic development and job growth in the St. Louis region. To accomplish this, BioGenerator identifies promising technologies and services, and works with the researcher or entrepreneur to build a successful and sustainable company. BioGenerator provides assistance, possibly with pre-seed or seed funding, at the early stages of new company formation, with continued support to milestones of follow-on funding or sustainable revenue. BioGenerator invests up to $50,000 for pre-seed companies and up to $250,000 for seed stage companies. The BioGenerator Seed Fund was launched in 2003 to provide an early stage investment mechanism for regional plant and life science companies. BioGenerator Seed companies have received up to $250K in BioGenerator cash investment. BioGenerator's Spark Fund and i6 Project are pre-seed funding programs for earlier stage companies. Spark Fund investments are capped at $50K. Regardless of the fund, most BioGenerator investments are syndicated with additional investors. BioGenerator occasionally makes very small scale investments in early stage companies or even technologies at the pre-company stage.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Charlie Bolten Vice President
    Dan Broderick Vice President
    Edward Hamati Director of Capital Formation
    Eric Gulve PhD President
    Eric Miller PhD Senior Analyst


    Portfolio companies include:

      Accuronix Therapeutics

      Adarza BioSystems
        web link

        web link

      Apertus Pharmaceuticals
        web link

        web link

      Apt Therapeutics
        web link

      Arch Innotek
        web link

        web link

      ARTA Bioscience
        web link

        web link

        web link

        web link

      Benson Hill Biosystems

      Canopy Biosciences

        web link

      Cofactor Genomics
        web link

      Confluence Discovery
        web link

      Confluence Life Sciences
        web link

      Daya CNS

      Edison Agrosciences
        web link

        web link

      Elira Therapeutics

        web link

      Euclises Pharmaceuticals
        web link

      Galera Therapeutics
        web link

        web link

        web link

        web link

      Indalo Therapeutics
        web link

      ISW Group
        web link

      Katalyst Surgical
        web link

      Kogent Surgical
        web link

        web link

        web link

        web link

        web link

        web link

      Midway Food Animal Sciences
        web link

      Mobius Therapeutics
        web link

        web link

        web link

      PixelEXX Systems
        web link

      Pulse Therapeutics
        web link

        web link

        web link

        web link

        web link

      WashU-1 Technology
        web link

      X-tend Energy
        web link


    Recent News: